CRTX Key Stats
- Nasdaq stocks posting largest percentage increases May 20
- Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Prop... May 14
- Cornerstone Therapeutics Management Discusses Q1 2013 Results - Earnings Call Tr... May 9
- CORNERSTONE THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitiv... May 9
- Q1 2013 Cornerstone Therapeutics Inc. Earnings Release - Before Market Open May 9
- Cornerstone Therapeutics Reports First Quarter 2013 Financial Results Marketwired May 9
- Cornerstone (CRTX) Acquires U.S. Marketing Rights to PERTZYE Street Insider May 9
- Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE(R) ... May 9
- Zacks #5 Rank Additions for Thursday - Tale of the Tape Zacks May 9
- REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call Marketwired May 8
CRTX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cornerstone Therapeutics is up 69.54% over the last year vs S&P 500 Total Return up 27.77%, Insmed up 331.0%, and China Biologic Products up 234.4%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for CRTX
Pro Report PDF for CRTX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download CRTX Pro Report PDF
Pro Strategies Featuring CRTX
Did Cornerstone Therapeutics make it into our Pro Portfolio Strategies?